The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival
Authors:
- 1 June 2020
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 73 (5) , 794-801
Abstract
The association between cancer-induced weight-loss (CIWL) and poor clinical outcomes in patients treated with immunotherapy is scarcely understood. We evaluated the use of a cachexia-grading system...Keywords
Funding Information
- CLICaP
This publication has 17 references indexed in Scilit:
- Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceClinical Cancer Research, 2018
- The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trialSupportive Care in Cancer, 2018
- Immunotherapy in NSCLC: A Promising and Revolutionary Weapon2017
- ESPEN guidelines on nutrition in cancer patientsClinical Nutrition, 2017
- Early and Intensive Dietary Counseling in Lung Cancer Patients Receiving (Chemo)Radiotherapy—A Pilot Randomized Controlled TrialNutrition and Cancer, 2016
- Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung CancerThe Oncologist, 2015
- Cachexia: clinical features when inflammation drives malnutritionProceedings of the Nutrition Society, 2015
- Diagnostic Criteria for the Classification of Cancer-Associated Weight LossJournal of Clinical Oncology, 2015
- Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective StudyNutrition and Cancer, 2012
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011